| 1 |
Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer[J]. Cancer Cell, 2008,13(1):58-68.
|
| 2 |
Hu XC, Loo WT, Chow LW. Surgery-related shedding of breast cancer cells as determined by RT-PCR assay[J]. J Surg Oncol, 2003,82(4):228-233.
|
| 3 |
Ismail MS, Wynendaele W, Aerts JL, et al. Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR[J]. Clin Cancer Res, 2004,10:196-201.
|
| 4 |
Biggers B, Knox S, Grant M, et al. Circulating tumor cells in patients undergoing surgery for primary breast cancer:preliminary results of a pilot study[J].Ann Surg Oncol, 2009,16(4):969-971.
|
| 5 |
Gilbey AM, Burnett D, Coleman RE, et al. The detection of circulating cancer cells in blood[J]. J Clin Pathol, 2004,57(5):903-908.
|
| 6 |
Mostert B, Sleijfer S, Foekens JA, et al. Circulating tumor cells (CTCs):detection methods and their clinical relevance in breast cancer[J]. Cancer Treat Rev, 2009,35(5):463-474
|
| 7 |
Hou JM, Krebs MG, Iancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboil in patients with small-cell lung cancer[J]. J Clin Oncol, 2012,30(2):525-532.
|
| 8 |
Linuma H, Watanabe T, Mimori K, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, inperpheral blood for recurrence and prognosis in patients with Dukes′ stage B and C colorectal cancer[J]. J Clin Oncol, 2011,29(2):1547-1555.
|
| 9 |
李蕾，江泽飞. 循环肿瘤细胞检测在不同阶段、不同类型乳腺癌中的应用[J]. 中国癌症杂志, 2013,23(8):570-575.
|
| 10 |
Riethdorf S, Muller V, Zhang L, et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant Gepar Quattro trial[J]. Clin Cancer Res, 2010,16(9):2634-2645.
|
| 11 |
Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression,and survival in metastatic breast cancer[J]. N Engl J Med, 2004,351(8):781-791.
|
| 12 |
Jiang ZF, Cristofanilli M, Shao ZM, et al. Circulating tumor cells predict progression-free and overallsurvival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter,double-blind, prospective trial[J]. Ann Oncol, 2013,24(11):2766-2772.
|
| 13 |
Tewes M, Aktas B, Welt A, et a1. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast concer：an option for monitoring response to breast cancer related therapies[J]. Breast Concer Res Treat, 2009,115(3):581-90.
|
| 14 |
李蕾，刘毅，张少华, 等. 循环肿瘤细胞检测在不同阶段、不同类型乳腺癌中的应用及意义[J]. 中华医学杂志, 2014,94(36):2812-2815.
|
| 15 |
Smerage JB, Hayes DF, Doyle GV, et a1. Assessment of circulating tumor cells in breast callcer patients undergoing neoadjuvant chemotherapy[J]. J Clin Oncol, 2006, 24(18S):1079-1085．
|
| 16 |
Camara O, Rengsberger M, Egbe A, et aI. The relevance of circulating epithelial tumor cells(CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer[J]. Ann Oncol, 2007,18(9):1484-1492．
|
| 17 |
Fehm T, Sagalowsky A, Clifford E, et a1. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant[J]. Clin Cancer Res, 2002,8(7):2073-2084.
|
| 18 |
Pogue-Geile KL, Kim C, Jeong JH, et al. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31[J]. J Natl Cancer Inst, 2013,105:1782-1788.
|
| 19 |
Meng SD, Tripathy D, Shete S, et a1. HER-2 gene amplification can be acquired as breast cancer progresses[J]. Proc Natl Acad Sci, 2004,101(25):9393-9398.
|
| 20 |
Wulfing P, Borchard J, Buerger H, et a1. HER2-Positive circulating tumor cells indicate poor clinical outcome in stage I to Ⅲ breast callcer patients[J]. Clin Cancer Res, 2006,12(6):1715-1720.
|
| 21 |
Reuben JM, Lee BN, Broglio KR, et a1. Genomic of circulating tumor cells in inmetastatic breast cancer[J]. J Clin Oncol, 2007,25(18S):1002.
|